Irinotecan is a chemotherapy agent that is a topoisomerase 1 inhibitor.

Its main use is in colon cancer, particularly in combination with other chemotherapy agents. This includes the regimen FOLFIRI which consists of infusional 5-fluorouracil, leucovorin, and irinotecan.

Irinotecan is marketed by Pfizer as Camptosar®. It is also known as CPT-11.

More on [ Irinotecan ]

Irinotecan - Twitter Search

phase 1/1b dose escalation stdy evaluating bsi-201 as single agent & in combo w/ irinotecan in ppl w/ advanced solid http://bit.ly/4HiQDb
usclinicaltrial (US Clinical Trials) Wed, 06 Jan 2010 06:58:15 -0000
phase 1/1b dose escalation stdy evaluating bsi-201 as single agent & in combo w/ irinotecan in ppl w/ advanced solid http://bit.ly/4HiQDb
phase 1/1b dose escalation stdy evaluating bsi-201 as single agent & in combo w/ irinotecan in ppl w/ advanced solid http://bit.ly/7bx5dw
cancertrials_ (Cancer Trials) Wed, 06 Jan 2010 06:58:14 -0000
phase 1/1b dose escalation stdy evaluating bsi-201 as single agent & in combo w/ irinotecan in ppl w/ advanced solid http://bit.ly/7bx5dw
Irinotecan RSS feed